Pachychoroid Spectrum Disorders: An Updated Review

Abstract Pachychoroid disease spectrum is a recent term that has been associated with an increasing number of phenotypes. This review discusses updated findings for each of the typical pachychoroid entities (central serous chorioretinopathy, pachychoroid pigment epitheliopathy, pachychoroid neovasculopathy, polypoidal choroidal vasculopathy, peripapillary pachychoroid syndrome, and focal choroidal excavation), as well as two relatively new additions (peripapillary pachychoroid neovasculopathy and peripheral exudative hemorrhagic chorioretinopathy). Here, we discuss the potential pathogenic mechanisms for these diseases and relevant imaging updates. Finally, we argue for a consistent classification scheme for these entities.

[1]  K. Falavarjani,et al.  Differentiating a pachychoroid and healthy choroid using an unsupervised machine learning approach , 2022, Scientific Reports.

[2]  A. Tsujikawa,et al.  Choriocapillaris flow deficit in a pachychoroid spectrum disease using en face optical coherence tomography angiography averaging , 2022, PloS one.

[3]  Xiongze Zhang,et al.  Detection of pachychoroid neovasculopathy with optical coherence tomography angiography versus dye angiography imaging. , 2022, Photodiagnosis and photodynamic therapy.

[4]  S. Demirel,et al.  A Comparative Study of Short-Term Vascular and Stromal Alterations of the Choroid Following Half-Fluence Photodynamic Therapy in Pachychoroid Neovasculopathy and Chronic Central Serous Chorioretinopathy , 2022, Life.

[5]  A. Invernizzi,et al.  Imaging-based Assessment of Choriocapillaris: A Comprehensive Review , 2022, Seminars in ophthalmology.

[6]  R. Adelman,et al.  A case of extrafoveal focal choroidal excavation , 2022, American Journal of Ophthalmology Case Reports.

[7]  C. Cheung,et al.  Relationship between Pachychoroid and Polypoidal Choroidal Vasculopathy , 2022, Journal of clinical medicine.

[8]  H. Akiyama,et al.  Occlusion of a Vortex Vein After Treatment With Half-Fluence Photodynamic Therapy Combined With Intravitreal Aflibercept Injection for Pachychoroid Neovasculopathy , 2022, Cureus.

[9]  Peng Yan,et al.  Updated review: optical coherence tomography findings of the pachychoroid disease spectrum. , 2022, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[10]  A. Tsujikawa,et al.  Natural Course of Pachychoroid Pigment Epitheliopathy , 2022, Ophthalmology science.

[11]  Mengyang Li,et al.  Case series: pachychoroid pigment epitheliopathy transformed to polypoidal choroidal vasculopathy after long-term follow-up , 2022, BMC Ophthalmology.

[12]  J. Chhablani,et al.  Accommodation Is Decreased in Eyes with Acute Central Serous Chorioretinopathy , 2022, Optometry and vision science : official publication of the American Academy of Optometry.

[13]  S. Demirel,et al.  Visualization of Type-1 Macular Neovascularization Secondary to Pachychoroid Spectrum Diseases: A Comparative Study for Sensitivity and Specificity of Indocyanine Green Angiography and Optical Coherence Tomography Angiography , 2022, Diagnostics.

[14]  I. Georgalas,et al.  Peripapillary Pachychoroid Syndrome (PPS): Diagnosing and Treating a Rare Entity , 2022, Case reports in ophthalmological medicine.

[15]  S. Kishi,et al.  A new insight into pachychoroid diseases: Remodeling of choroidal vasculature , 2022, Graefe's Archive for Clinical and Experimental Ophthalmology.

[16]  S. Priglinger,et al.  Progression of pachychoroid neovasculopathy into aneurysmal type 1 choroidal neovascularization or polypoidal choroidal vasculopathy. , 2022, Ophthalmology. Retina.

[17]  Jaeryung Oh,et al.  Factors related to the location of pigment epithelial detachment in central serous chorioretinopathy , 2022, Scientific Reports.

[18]  O. Meijer,et al.  Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities , 2022, Acta ophthalmologica.

[19]  Shanna C. Yeung,et al.  The effect of systemic and topical ophthalmic medications on choroidal thickness: A review , 2022, British journal of clinical pharmacology.

[20]  Jano van Hemert,et al.  Choroidal vascular alterations evaluated by ultra-widefield indocyanine green angiography in central serous chorioretinopathy , 2022, Graefe's Archive for Clinical and Experimental Ophthalmology.

[21]  D. Sarraf,et al.  An unusual presentation of peripapillary pachychoroid syndrome , 2022, American journal of ophthalmology case reports.

[22]  K. Freund,et al.  Ultra-Widefield Indocyanine Green Angiography Reveals Patterns of Choroidal Venous Insufficiency Influencing Pachychoroid Disease , 2022, Investigative ophthalmology & visual science.

[23]  A. Casuccio,et al.  Polypoidal choroidal vasculopathy in pachychoroid: combined treatment with photodynamic therapy and aflibercept , 2021, International Ophthalmology.

[24]  S. Sivaprasad,et al.  Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders , 2021, Progress in Retinal and Eye Research.

[25]  Ratnesh Ranjan,et al.  Photodynamic therapy for peripapillary pachychoroid syndrome-a case report. , 2022, Digital journal of ophthalmology : DJO.

[26]  G. Cennamo,et al.  Structural and Vascular Changes of the Choroid in Polypoidal Choroidal Vasculopathy after Intravitreal Anti-VEGF Therapy , 2021, Ophthalmologica.

[27]  F. Behar-Cohen,et al.  Potential Treatment for Peripapillary Pachychoroid Syndrome , 2021, RETINAL Cases & Brief Reports.

[28]  A. Young,et al.  The Contemporary Role of Photodynamic Therapy in the Treatment of Pachychoroid Diseases , 2021, Journal of ophthalmology.

[29]  A. Orlin,et al.  Primary and secondary focal choroidal excavation morphologic phenotypes, associated ocular disorders and prognostic implications , 2021, British Journal of Ophthalmology.

[30]  M. Lupidi,et al.  One-year outcome of cystoid macular degeneration in central serous chorioretinopathy , 2021, European journal of ophthalmology.

[31]  F. Wen,et al.  CORRELATION BETWEEN FOCAL CHOROIDAL EXCAVATION AND UNDERLYING RETINOCHOROIDAL DISEASE , 2021, Retina.

[32]  A. Tsujikawa,et al.  Pachychoroid‐phenotype effects on 5‐year visual outcomes of anti‐VEGF monotherapy in polypoidal choroidal vasculopathy , 2021, Acta ophthalmologica.

[33]  T. Kawano,et al.  Morphological differences of choroid in central serous chorioretinopathy determined by ultra-widefield optical coherence tomography , 2021, Graefe's Archive for Clinical and Experimental Ophthalmology.

[34]  B. Takkar,et al.  Pachychoroid neovasculopathy: A comparative review on pathology, clinical features, and therapy , 2021, European journal of ophthalmology.

[35]  Ratnesh Ranjan,et al.  Posterior choroidal fluid loculation in central serous chorioretinopathy presenting as a choroidal elevation: A rare Pachychoroid phenotype , 2021, European journal of ophthalmology.

[36]  A. Loewenstein,et al.  Photodynamic therapy as a treatment option for peripapillary pachychoroid syndrome: a pilot study , 2021, Eye.

[37]  P. Sen,et al.  A case of peripapillary pachychoroid syndrome treated with anti-vascular endothelial growth factor injections , 2021 .

[38]  S. Demirel,et al.  A comparative study on the choroidal vascularity index and the determination of cut-off values in the pachychoroid spectrum diseases , 2021, Japanese Journal of Ophthalmology.

[39]  Jaeryung Oh,et al.  Clustering of eyes with age-related macular degeneration or pachychoroid spectrum diseases based on choroidal thickness profile , 2021, Scientific Reports.

[40]  R. Agrawal,et al.  Choroidal and Retinal Changes After Systemic Adrenaline and Photodynamic Therapy in Non-Human Primates , 2021, Investigative ophthalmology & visual science.

[41]  S. Sadda,et al.  Long-term visual and anatomic outcomes of patients with peripapillary pachychoroid syndrome , 2020, British Journal of Ophthalmology.

[42]  J. Chhablani,et al.  PERIPHERAL EXUDATIVE HEMORRHAGIC CHORIORETINOPATHY-A NEW ADDITION TO THE SPECTRUM OF PACHYCHOROID DISEASE? , 2020, Retina.

[43]  Gabriella Moraes,et al.  Pachychoroid spectrum disease , 2020, Acta ophthalmologica.

[44]  A. Tsujikawa,et al.  Deep phenotype unsupervised machine learning revealed the significance of pachychoroid features in etiology and visual prognosis of age-related macular degeneration , 2020, Scientific Reports.

[45]  R. Spaide,et al.  Intervortex Venous Anastomosis in Pachychoroid-Related Disorders. , 2020, Retina.

[46]  J. Chae,et al.  Choroidal inflammation and choriocapillaris ischemia in focal choroidal excavation in comparison to pachychoroid neovasculopathy. , 2020, Retina.

[47]  R. Spaide,et al.  Choriocapillaris Vascular Parameters in Normal Eyes and Those with Pachychoroid with and without Disease. , 2020, Retina.

[48]  T. Lai,et al.  Pachychoroid: current concepts on clinical features and pathogenesis , 2020, Graefe's Archive for Clinical and Experimental Ophthalmology.

[49]  V. Castro Navarro,et al.  Peripapillary pachychoroid neovasculopathy: A novel entity , 2020, European journal of ophthalmology.

[50]  R. Chawla,et al.  Focal choroidal excavation: review of literature , 2020, British Journal of Ophthalmology.

[51]  H. Koizumi,et al.  Scleral Thickness in Central Serous Chorioretinopathy. , 2020, Ophthalmology. Retina.

[52]  S. Yzer,et al.  Treatment of Peripapillary Pachychoroid Syndrome , 2020 .

[53]  D. Maltsev,et al.  Effect of Topical Pilocarpine on Choroidal Thickness in Healthy Subjects , 2020, Optometry and vision science : official publication of the American Academy of Optometry.

[54]  T. Nakazawa,et al.  Systemic oxidative stress level in patients with central serous chorioretinopathy , 2020, Graefe's Archive for Clinical and Experimental Ophthalmology.

[55]  S. Kishi,et al.  Vortex Vein Anastomosis at the Watershed in Pachychoroid Spectrum Diseases. , 2020, Ophthalmology. Retina.

[56]  K. Vupparaboina,et al.  Anterior Sclera Undergoes Thinning with Increasing Degree of Myopia , 2020, Investigative ophthalmology & visual science.

[57]  Tatsuya Inoue,et al.  One-year outcome of combination therapy with intravitreal anti-vascular endothelial growth factor and photodynamic therapy in patients with pachychoroid neovasculopathy , 2020, Graefe's Archive for Clinical and Experimental Ophthalmology.

[58]  J. Sambricio,et al.  Diagnosis by multimodal imaging in peripapillary pachychoroid syndrome: A case report. , 2020 .

[59]  M. Morimoto,et al.  One-year outcomes of half-fluence photodynamic therapy combined with intravitreal injection of aflibercept for pachychoroid neovasculopathy without polypoidal lesions , 2020, Japanese Journal of Ophthalmology.

[60]  Soo Ick Cho,et al.  Association of Irregular Pigment Epithelial Detachment in Central Serous Chorioretinopathy with Genetic Variants Implicated in Age-related Macular Degeneration , 2020, Scientific Reports.

[61]  K. Freund,et al.  RELATIONSHIP BETWEEN CHOROIDAL VASCULAR HYPERPERMEABILITY, CHORIOCAPILLARIS FLOW DENSITY, AND CHOROIDAL THICKNESS IN EYES WITH PACHYCHOROID PIGMENT EPITHELIOPATHY. , 2020, Retina.

[62]  Cheng-Kuo Cheng,et al.  DIFFERENCE BETWEEN PACHYCHOROID AND NONPACHYCHOROID POLYPOIDAL CHOROIDAL VASCULOPATHY AND THEIR RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. , 2020, Retina.

[63]  C. Hoyng,et al.  CLINICAL CHARACTERISTICS AND OUTCOME OF POSTERIOR CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY , 2019, Retina.

[64]  C. Sotozono,et al.  Short axial length and hyperopic refractive error are risk factors of central serous chorioretinopathy , 2019, British Journal of Ophthalmology.

[65]  R. Tadayoni,et al.  Central serous chorioretinopathy: risk factors for serous retinal detachment in fellow eyes , 2019, British Journal of Ophthalmology.

[66]  C. Jin,et al.  Comparison between non-visualized polyps and visualized polyps on optical coherence tomography angiography in polypoidal choroidal vasculopathy , 2019, Graefe's Archive for Clinical and Experimental Ophthalmology.

[67]  S. Kishi,et al.  Remodeling of macular vortex veins in pachychoroid neovasculopathy , 2019, Scientific Reports.

[68]  D. Kumawat,et al.  Pachychoroid Spectrum Disorders: A Review of Clinical Features and Management , 2019, Delhi Journal of Ophthalmology.

[69]  Kiran Kumar Vupparaboina,et al.  Choroidal imaging biomarkers. , 2019, Survey of ophthalmology.

[70]  W. Lee,et al.  Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy , 2019, Scientific Reports.

[71]  J. Chhablani,et al.  Management of chronic central serous chorioretinopathy , 2018, Indian journal of ophthalmology.

[72]  S. Sonoda,et al.  Geographic filling delay of the choriocapillaris in the region of dilated asymmetric vortex veins in central serous chorioretinopathy , 2018, PloS one.

[73]  You-xin Chen,et al.  Choroid changes in vortex vein-occluded monkeys. , 2018, International journal of ophthalmology.

[74]  Hyewon Chung,et al.  Changes in Stromal and Luminal Areas of the Choroid in Pachychoroid Diseases: Insights Into the Pathophysiology of Pachychoroid Diseases. , 2018, Investigative ophthalmology & visual science.

[75]  W. Lee,et al.  Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy , 2018, Graefe's Archive for Clinical and Experimental Ophthalmology.

[76]  M. Ersoz,et al.  Long-term follow-up of pachychoroid pigment epitheliopathy and lesion characteristics , 2018, Graefe's Archive for Clinical and Experimental Ophthalmology.

[77]  C. Sotozono,et al.  Distinct Aqueous Humour Cytokine Profiles of Patients with Pachychoroid Neovasculopathy and Neovascular Age-related Macular Degeneration , 2018, Scientific Reports.

[78]  J. Caminal,et al.  Changes in Choroidal Thickness After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor in Pachychoroid Neovasculopathy. , 2018, Investigative ophthalmology & visual science.

[79]  L. Yannuzzi,et al.  Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy): a lesson in the taxonomy of ‘expanded spectra’ – a review , 2017, Clinical & experimental ophthalmology.

[80]  P. Keane,et al.  PERIPAPILLARY PACHYCHOROID SYNDROME , 2017, Retina.

[81]  Min Zhao,et al.  SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY , 2015, Retina.

[82]  H. Iijima,et al.  CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY , 2017, Retina.

[83]  Y. Teo,et al.  Shared genetic variants for polypoidal choroidal vasculopathy and typical neovascular age-related macular degeneration in East Asians , 2017, Journal of Human Genetics.

[84]  A. Loewenstein,et al.  Eplerenone for chronic central serous chorioretinopathy–a randomized controlled prospective study , 2017, Acta ophthalmologica.

[85]  Shibo Tang,et al.  Clinical efficacy of anti-VEGF medications for central serous chorioretinopathy: a meta-analysis , 2017, International Journal of Clinical Pharmacy.

[86]  C. Cheung,et al.  Choroidal structures in polypoidal choroidal vasculopathy, neovascular age-related maculopathy, and healthy eyes determined by binarization of swept source optical coherence tomographic images , 2017, Graefe's Archive for Clinical and Experimental Ophthalmology.

[87]  Yoneyama Seigo,et al.  ポリープ状脈絡膜血管症におけるpachychoroid neovasculopathyの遺伝的・臨床的特徴 , 2017 .

[88]  A. Tsujikawa,et al.  Intraocular Vascular Endothelial Growth Factor Levels in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration. , 2017, Investigative ophthalmology & visual science.

[89]  K. Freund,et al.  CHOROIDAL MORPHOLOGY IN EYES WITH POLYPOIDAL CHOROIDAL VASCULOPATHY AND NORMAL OR SUBNORMAL SUBFOVEAL CHOROIDAL THICKNESS , 2016, Retina.

[90]  R. Agrawal,et al.  CHOROIDAL VASCULARITY INDEX IN CENTRAL SEROUS CHORIORETINOPATHY , 2016, Retina.

[91]  S. Sonoda,et al.  Structural analyses of choroid after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy , 2016, British Journal of Ophthalmology.

[92]  W. Lee,et al.  ONE-YEAR RESULTS OF ADJUNCTIVE PHOTODYNAMIC THERAPY FOR TYPE 1 NEOVASCULARIZATION ASSOCIATED WITH THICKENED CHOROID , 2016, Retina.

[93]  K. Freund,et al.  EN FACE IMAGING OF PACHYCHOROID SPECTRUM DISORDERS WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY , 2016, Retina.

[94]  T. Wong,et al.  Choroidal vascularity index as a measure of vascular status of the choroid: Measurements in healthy eyes from a population-based study , 2016, Scientific Reports.

[95]  K Bailey Freund,et al.  Optical Coherence Tomography Angiography of Shallow Irregular Pigment Epithelial Detachments In Pachychoroid Spectrum Disease. , 2015, American journal of ophthalmology.

[96]  A. Tsujikawa,et al.  Pachychoroid neovasculopathy and age-related macular degeneration , 2015, Scientific Reports.

[97]  A. Trost,et al.  Lymphatic Markers in the Adult Human Choroid. , 2015, Investigative ophthalmology & visual science.

[98]  F. Koch,et al.  Randomized Clinical Trial to Compare Micropulse Photocoagulation Versus Half-dose Verteporfin Photodynamic Therapy in the Treatment of Central Serous Chorioretinopathy. , 2015, Ophthalmic surgery, lasers & imaging retina.

[99]  Robert P. Cubbidge,et al.  Measurement of Scleral Thickness in Humans Using Anterior Segment Optical Coherent Tomography , 2015, PloS one.

[100]  M. Yuzawa,et al.  MORPHOLOGIC FEATURES OF FOCAL CHOROIDAL EXCAVATION ON SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY WITH SIMULTANEOUS ANGIOGRAPHY , 2014, Retina.

[101]  F. Türkçü,et al.  Psychological Distress and Poor Quality of Life in Patients with Central Serous Chorioretinopathy , 2014, Seminars in ophthalmology.

[102]  F. Geiser,et al.  Temperament and Character Personality Profile and Illness-Related Stress in Central Serous Chorioretinopathy , 2014, TheScientificWorldJournal.

[103]  Yoo-Ri Chung,et al.  Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review , 2013, Eye.

[104]  A. Tsujikawa,et al.  Focal choroidal excavation in eyes with central serous chorioretinopathy. , 2013, American journal of ophthalmology.

[105]  James G Fujimoto,et al.  Analysis of choroidal morphologic features and vasculature in healthy eyes using spectral-domain optical coherence tomography. , 2013, Ophthalmology.

[106]  H. Enaida,et al.  Symptomatic and Morphological Differences between Choroidal Excavations , 2013, Optometry and vision science : official publication of the American Academy of Optometry.

[107]  K. Freund,et al.  PERIPHERAL POLYPOIDAL CHOROIDAL VASCULOPATHY AS A CAUSE OF PERIPHERAL EXUDATIVE HEMORRHAGIC CHORIORETINOPATHY: A Report of 10 Eyes , 2013, Retina.

[108]  G. Yılmaz,et al.  Clinical characteristics of peripheral exudative hemorrhagic chorioretinopathy and its response to bevacizumab therapy , 2013, Eye.

[109]  L. Yannuzzi,et al.  TYPE 1 (SUB-RETINAL PIGMENT EPITHELIAL) NEOVASCULARIZATION IN CENTRAL SEROUS CHORIORETINOPATHY MASQUERADING AS NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2012, Retina.

[110]  I. Mantel,et al.  Peripheral exudative hemorrhagic chorioretinopathy: polypoidal choroidal vasculopathy and hemodynamic modifications. , 2012, American journal of ophthalmology.

[111]  L. Yannuzzi TYPE-A BEHAVIOR AND CENTRAL SEROUS CHORIORETINOPATHY , 2012, Retina.

[112]  Michael D. Ober,et al.  The expanded spectrum of focal choroidal excavation. , 2011, Archives of ophthalmology.

[113]  T. Higashide,et al.  Unilateral choroidal excavation in the macula detected by spectral‐domain optical coherence tomography , 2009, Acta ophthalmologica.

[114]  R. Spaide,et al.  ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY OF THE CHOROID IN CENTRAL SEROUS CHORIORETINOPATHY , 2009, Retina.

[115]  C. Shields,et al.  Peripheral exudative hemorrhagic chorioretinopathy simulating choroidal melanoma in 173 eyes. , 2009, Ophthalmology.

[116]  T. Lai,et al.  SAFETY ENHANCED PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: One-Year Results of a Prospective Study , 2008, Retina.

[117]  M. Mandai,et al.  Pigment epithelial detachment in polypoidal choroidal vasculopathy. , 2007, American journal of ophthalmology.